Company

aTYR PHARMA INC (ATYR)

Standardized SEC financial data for aTYR PHARMA INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001339970 · NASDAQ · Biological Products, (No Diagnostic Substances).

Revenue growth (YoY)

-19.1%

Return on equity

-110.2%

ROIC

-93.9%

Free cash flow

-$62.1M

Debt / equity

0.13×

Current ratio

5.30×

EPS (diluted)

$-0.80

Ratios for fiscal year 2025, standardized from SEC filings.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$10.5M	$0	$10.4M	$353K	$235K	$190K
R&D expense	$17.3M	$23.3M	$42.8M	$42.3M	$54.4M	$60.2M
SG&A expense	$9.1M	$10.8M	$14.0M	$13.0M

Balance sheet

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$17.0M	$2.3M	$10.0M	$22.5M	$11.1M	$10.7M
Total current assets	$35.5M	$113.6M	$80.9M	$103.0M	$82.0M	$80.2M
Property, plant & equipment	$899K	$543K	$3.1M	$5.5M

Cash flow

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	-$15.3M	-$33.1M	-$41.9M	-$33.2M	-$69.1M	-$62.0M
Capital expenditures	$202K	$192K	$1.6M	$4.2M	$65K	$77K
Free cash flow	-$15.5M	-$33.3M	-$43.5M	-$37.4M

Get ATYR data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ATYR/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ATYR/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View ATYR filings on SEC EDGAR →